Cohen Fred E

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Cohen Fred E
CIK #0001339358
EDGAR Form CIK 2011 - 2026
3 [0001339358]
4 [0001339358]
Form 3/4/5 Subject 2011 - 2026
CareDx Inc
Cohen Fred E
Intellia Therapeutics Inc
Kyverna Therapeutics Inc
UroGen Pharma Ltd
Progyny Inc
Veracyte Inc
Genomic Health Inc
Tandem Diabetes Care Inc
Biocryst Pharmaceuticals Inc
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Intellia Therapeutics Inc NTLA
Common Stock
2026-01-05 Buy 150,000 $9.35 1,402,500
CareDx Inc CDNA
Common Stock
2025-06-13 Grant 12,103 $0.00
Intellia Therapeutics Inc NTLA
Common Stock
2025-06-11 Grant 8,000 $0.00
Intellia Therapeutics Inc NTLA
Stock Option (right to buy) · derivative
2025-06-11 Grant 11,450 $0.00
Kyverna Therapeutics Inc KYTX
Common Stock
2025-05-29 Grant 16,634 $0.00
Kyverna Therapeutics Inc KYTX
Stock Option (right to buy) · derivative
2025-05-29 Grant 65,351 $0.00
UroGen Pharma Ltd URGN
Stock Option (right ot buy) · derivative
2024-08-06 Grant 10,000 $0.00
CareDx Inc CDNA
Common Stock
2024-06-14 Grant 10,570 $0.00
CareDx Inc CDNA
Stock Option (right to buy) · derivative
2024-06-14 Grant 16,048 $0.00
Intellia Therapeutics Inc NTLA
Common Stock
2024-06-12 Grant 7,737 $0.00
Intellia Therapeutics Inc NTLA
Stock Option (right to buy) · derivative
2024-06-12 Grant 11,515 $0.00
Progyny Inc PGNY
Common Stock
2024-05-23 Grant 6,176 $0.00
Progyny Inc PGNY
Stock Option (Right to Buy) · derivative
2024-05-23 Grant 25,070 $0.00
Kyverna Therapeutics Inc KYTX
Series A-1 Redeemable Convertible Preferred Stock · derivative
2024-02-12 Conversion 4,401,771 $0.00
Kyverna Therapeutics Inc KYTX
Common Stock
2024-02-12 Conversion 4,523,924
Kyverna Therapeutics Inc KYTX
Series A-2 Redeemable Convertible Preferred Stock · derivative
2024-02-12 Conversion 8,830,901 $0.00
Kyverna Therapeutics Inc KYTX
Series B Redeemable Convertible Preferred Stock · derivative
2024-02-12 Conversion 7,356,162 $0.00
UroGen Pharma Ltd URGN
Stock Option (right ot buy) · derivative
2023-09-07 Grant 10,000 $0.00
UroGen Pharma Ltd URGN
Ordinary Shares
2023-07-26 Grant 69,339 $9.54 661,494
CareDx Inc CDNA
Common Stock · derivative
2023-06-16 Grant 29,136 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com